Lv22
130 积分 2025-09-29 加入
USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I
43分钟前
已完结
Advances in Immunotherapy for Diffuse Large B Cell Lymphoma
19天前
已完结
DLBCL: Who is high risk and how should treatment be optimized?
1个月前
已完结
DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation and Practice in DLBCL
1个月前
已完结
PIM3-mediated phosphorylation stabilizes myeloid leukemia factor 2 to promote metastasis in osteosarcoma
1个月前
已完结
The hallmarks of cancer immune evasion
1个月前
已完结
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
1个月前
已完结
CD300ld on neutrophils is required for tumour-driven immune suppression
2个月前
已完结
皖公网安备34019202002308
